• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Portola Pharmaceuticals Inc

+ Add to Watchlist

PTLA:US

25.3100 USD 0.6000 2.32%

As of 20:10:00 ET on 08/21/2014.

Snapshot for Portola Pharmaceuticals Inc (PTLA)

Open: 25.9800 Day's Range: 25.2600 - 26.4700 Volume: 182,443
Previous Close: 25.9100 52wk Range: 19.5900 - 31.4800 1-Yr Rtn: +18.27%

Stock Chart for PTLA

No chart data available.
  • PTLA:US 25.2700
  • 1D
  • 1M
  • 1Y
25.9100
Interactive PTLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PTLA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.6700
Est. EPS (USD) (12/2014) -3.4220
Est. PEG Ratio -
Market Cap (M USD) 1,047.75
Shares Outstanding (M) 41.40
30 Day Average Volume 245,870
Price/Book (mrq) 4.3314
Price/Sale (ttm) 102.4216
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PTLA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PTLA

Portola Pharmaceuticals, Inc. provides specialty pharmaceutical products. The Company offers novel therapeutics for thrombosis, hematologic disorders, and inflammation. Portola Pharmaceuticals serves customers in the United States.

Charles J HomcyCo-Chairman/Co-FounderHollings C RentonCo-Chairman
William LisChief Executive OfficerMardi C DierExec VP/CFO
More Company Profile & Key Executives for PTLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil